SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-049263
Filing Date
2024-02-28
Accepted
2024-02-28 08:11:56
Documents
16
Period of Report
2024-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d772021d8k.htm   iXBRL 8-K 29795
2 EX-99.1 d772021dex991.htm EX-99.1 184026
  Complete submission text file 0001193125-24-049263.txt   392496

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nams-20240228.xsd EX-101.SCH 4098
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nams-20240228_def.xml EX-101.DEF 13741
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nams-20240228_lab.xml EX-101.LAB 22929
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nams-20240228_pre.xml EX-101.PRE 14709
18 EXTRACTED XBRL INSTANCE DOCUMENT d772021d8k_htm.xml XML 6053
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 24690300
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)